ym 264 has been researched along with ym 461 in 2 studies
| Studies (ym 264) | Trials (ym 264) | Recent Studies (post-2010) (ym 264) | Studies (ym 461) | Trials (ym 461) | Recent Studies (post-2010) (ym 461) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 5 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, H; Mase, T; Matsuhisa, A; Nagaoka, H; Saito, M; Suzuki, T; Takahashi, T; Takeuchi, M; Tomioka, K; Yamada, T | 1 |
| Hara, H; Mase, T; Matsumoto, H; Nagaoka, H; Saito, M; Suzuki, T; Takanuki, K; Takeuchi, M; Tomioka, K; Yamada, T | 1 |
2 other study(ies) available for ym 264 and ym 461
| Article | Year |
|---|---|
2-(3-Pyridyl)thiazolidine-4-carboxamides. 1. Novel orally active antagonists of platelet-activating factor (PAF).
Topics: Animals; Capillary Permeability; Guinea Pigs; Hematocrit; Humans; Mice; Piperazines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Rabbits; Rats; Rats, Wistar; Species Specificity; Structure-Activity Relationship; Thiazoles; Thiazolidines | 1997 |
2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. III.) Synthesis of metabolites and metabolism of 2-(3-pyridyl)thiazolidine-4-carboxamides YM461 and YM264 as platelet-activating factor (PAF) receptor antagonists.
Topics: Administration, Oral; Animals; Area Under Curve; Biotransformation; Chromatography, High Pressure Liquid; Dogs; In Vitro Techniques; Injections, Intravenous; Macaca mulatta; Male; Piperazines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Pyridines; Rabbits; Rats; Rats, Inbred F344; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles; Thiazolidines | 1999 |